X4 Pharmaceuticals, Inc.XFORNASDAQ
Loading
Stockholders Equity Over TimeExpanding
Percentile Rank100
3Y CAGR+36.0%
5Y CAGR+20.7%
Studio
Year-over-Year Change

Net worth of the company (assets minus liabilities)

3Y CAGR
+36.0%/yr
vs +36.1%/yr prior
5Y CAGR
+20.7%/yr
Recent acceleration
Acceleration
-0.1pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.6x
Strong expansion
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$186.29M+741.1%
2024$22.15M-56.7%
2023$51.10M-31.0%
2022$74.05M+15.0%
2021$64.41M-11.5%
2020$72.80M-43.7%
2019$129.22M+498.2%
2018$21.60M-63.2%
2017$58.71M+203.8%
2016$-56.56M-